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The prion protein is known to be a copper-binding
protein, but affinity and stoichiometry data for the full-
length protein at a physiological pH of 7 were lacking.
Furthermore, it was unknown whether only the highly
flexible N-terminal segment with its octarepeat region is
involved in copper binding or whether the structured
C-terminal domain is also involved. Therefore we sys-
tematically investigated the stoichiometry and affinity
of copper binding to full-length prion protein PrP23–231
and to different N- and C-terminal fragments using elec-
trospray ionization mass spectrometry and fluorescence
spectroscopy. Our data indicate that the unstructured
N-terminal segment is the cooperative copper-binding
domain of the prion protein. The prion protein binds up
to five copper(II) ions with half-maximal binding at ;2
mM. This argues strongly for a direct role of the prion
protein in copper metabolism, since it is almost satu-
rated at about 5 mM, and the exchangeable copper pool
concentration in blood is about 8 mM.
Prion diseases are fatal neurodegenerative diseases thought
to be caused by conformational transition of the native and
predominantly a-helical prion protein (PrPC)1 to the signifi-
cantly more b-sheet-containing pathogenic isoform (PrPSc) (1).
This conformational transition apparently induces the forma-
tion of PrPSc aggregates (2), which are, in contrast to PrPC,
highly protease-resistant (3). During infection, PrPSc appears
to serve as a template for the conversion of the native prion
protein, because host PrPC expression is required for infection
with prions (4). There is evidence that copper plays a role in the
formation of PrPSc (5).
PrPC is nearly ubiquitously distributed to all tissues. The
highest levels are found in the brain (6). Native PrPC is an
asparagine-linked sialoglycoprotein that is attached to the sur-
face of the plasma membrane via a C-terminal glycophosphati-
dylinositol anchor (7). The structured C-terminal half of the
full-length recombinant PrP23–231 (amino acids 23–231) from
amino acids 126–231 is made up of two strands of one small
antiparallel b-sheet and three a-helices (8). The N-terminal
half from amino acids 23–125 showed no structure in NMR
analysis and is therefore postulated to be highly flexible (9, 10).
Although many efforts have been made the physiological
function of PrPC has not yet been identified (11, 12). In 1995 it
was suggested that the octarepeat region ([PHGGGWGQ]4)
from amino acids 60–91 within the flexible N-terminal half of
the prion protein may play a role in binding copper (13). We
have shown that PrPC has indeed a function in synaptic copper
binding (14). Heavy metal binding studies indicated that PrPC
seems to specifically bind copper (15). Half-maximal binding of
two copper ions at 14 mM was reported for Syrian hamster
ShamPrP29–231 at pH 6.0 (15). In contrast, binding of 4 and 5.6
copper ions to the octarepeat region peptide (16, 17) and
humPrP23–98 (18) at pH 7.4 with half-maximal binding at about
6 mM were found, respectively. The copper binding to the octa-
repeat region was shown to be strongly pH-dependent in the
range from 5 to 7 (14) with almost no binding at pH 5.
The lack of affinity and stoichiometry data for the full-length
prion protein at a physiological pH of 7, as well as the question
of which part of the prion protein is responsible for the copper
binding, prompted us to systematically investigate the copper
binding to the full-length prion protein as well as to different
N- and C-terminal fragments using fluorescence spectroscopy
and electrospray ionization mass spectrometry.
In this paper we present for the first time copper binding
data on the full-length prion protein under physiological con-
ditions at pH 7. Our data show that the prion protein binds up
to five copper ions and is almost saturated at 5 mM copper(II).
Furthermore, our data suggest that the highly flexible N-ter-
minal half is the cooperative copper-binding domain of the
prion protein.
EXPERIMENTAL PROCEDURES
Materials and Reagents—MOPS, dodecyltrimethylammonium chlo-
ride, CuSO4z5H2O, and N-ethylmorpholine were purchased from Fluka
(Deisenhofen, Germany). Chelite P was obtained from Serva (Heidel-
berg, Germany). Ion exchange matrices EMD-COOH, EMD-TMAE, and
thrombin were ordered from Merck (Darmstadt, Germany). All other
reagents used were of analytical grade.
Synthesis and Purification of humPrP60–91 and humPrP60–109—The
peptides humPrP60–91 and humPrP60–109 were synthesized on an 9050-
peptide synthesizer (Millipore) using amino acids protected with Fmoc
(1-fluorenylmethoxycarbonyl) and activated with benzotriazol-1-yl-oxy-
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formance liquid chromatography; amu, average mass unit; MS, mass
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tris(pyrrolidino)phosphonium-hexafluorophoshpate (PyBOP) (19). Af-
ter cleavage from resin and removal of protecting groups, peptides were
first purified by reversed-phase HPLC using a 1.9 3 30-cm2 Delta Pac
C18 column (Millipore) with a gradient from 0 to 50% acetonitrile
including 0.1% trifluoroacetic acid for 50 min. Both peptides were
further purified on an EMD-COOH column eluting with a gradient from
0.02 to 1 M ammonium acetate, pH 5.0. Finally, peptides were purified
by reversed-phase HPLC on a Vydac C4 column (4 3 250 mm) using a
linear water acetonitrile gradient of 10–50% acetonitrile including 0.1%
trifluoroacetic acid.
Expression and Purification of Full-length murPrP23–231 and N-ter-
minal Fragments humPrP23–98 and humPrP23–112—The N-terminal
fragment humPrP23–98 was expressed in E. coli according to Brown et
al. (18). After expression and thrombin cleavage of the GST-
humPrP23–98 fusion protein, the reaction mixture was applied to an
EMD-COOH column and humPrP23–98 was eluted with a gradient from
0 M up to 1 M ammonium acetate pH 6.0.
The plasmid pEThuPrP23–112 was constructed for the expression of
humPrP23–112 following the cloning of the human PRNP ORF from
genomic DNA (20). The coding region of the N-terminal segment of PrP
(aa 23 to 112) was amplified via PCR under standard conditions using
primers huPrP23–112up (59-GGCCGGTCATGAAGAAGCGCCCGAAG-
CCT-39) and huPrP23–112do (59GCCGGGAATTCTTATCACATGTGC-
TTCATGTTGGT-39). Primer huPrP23–112up contains a BspHI clea-
vage site and a start codon. Primer huPrP23–112do contains two stop
codons and an EcoRI cleavage site. The construct was cloned into the
NcoI and EcoRI sites of the inducible expression vector pET-21d (Nova-
gen) and the sequence of the insert was verified by DNA sequence
analysis
The expression of the humPrP23–112 in E. coli was induced with
IPTG. Harvested cells were lysed with 1% Triton X-100 and centrifuged
at 18,500 g for 15 min. The supernatant was applied to an EMD-COOH
column, washed with 10 mM ammonium acetate pH 6.0. humPrP23–112
and eluted with a linear gradient up to 1 M ammonium acetate pH 6.0
from the column.
Finally, both N-terminal PrP fragments were purified by reversed
phase HPLC on a Vydac C4 column (4 mm x 250 mm) using a linear
water acetonitrile gradient of 10% to 50% acetonitrile including 0.1%
trifluoroacetic acid.
The full-length murPrP23–231 was expressed and purified according
to Liemann et al. (21). Before lyophilization, protein was dialyzed with
Chelite P to remove traces of bound copper. The C-terminal fragment
murPrP121–231 was expressed and purified as described earlier (22).
Fluorescence Titration of PrP23–231 and Its Fragments—Fluorescence
spectroscopy was carried out on an LS 50B from PerkinElmer Life
Sciences (Überlingen, Germany). Measurements were performed in 20
mM MOPS, pH 7.2, 100 mM NaCl, and 1 mM DTAC. MOPS buffer was
treated with Chelite P to remove traces of heavy metal ions. To excite
selectively tryptophan fluorescence, a wavelength of 295 nm was cho-
sen, and the fluorescence signal was detected on the emission side at
355 nm. Excitation slit width varied from 3 to 5 nm, and emission slit
width was in the range of 10–15 nm. For reasons of sensitivity the
excitation wavelength for murPrP121–231 was set to 285 nm. Copper
sulfate was added carefully to prevent possible precipitation (monitored
by systematic excitation peak broadening in the emission spectra). Each
point in the fluorescence titration curves represents the average of at
least three measurements. Fluorescence titrations were performed at
20 °C. Due to absorption of copper in the UV range, fluorescence titra-
tion curves were corrected for inner filter effect (23). All curves were
corrected for background fluorescence.
ESI Mass Spectrometry—Mass spectrometry of N-terminal PrP frag-
ments with and without copper were performed on a TSQ7000 (Finni-
gan) in the nano spray mode. The buffer was 1 mM NEMO/formic acid
at pH 7.4. The applied spray voltage was 0.8–1.0 kV. Capillary tem-
perature was set to 150 °C.
Peptide and Protein Quantification—Peptide and protein concentra-
tions were determined in 6 M guanidinium chloride according to Gill
and von Hippel (24). Peptide quantification by amino acid analysis for
humPrP60–91 resulted in identical values.
RESULTS
Electrospray Ionization Mass Spectrometry of Full-length
PrP23–231 and Its Fragments with Copper—ESI mass spectrom-
etry was used to elucidate the stoichiometry of copper binding
to the different N-terminal fragments humPrP60–91,
humPrP60–109, humPrP23–98, and humPrP23–112 as well as for
the C-terminal fragment murPrP121–231 and for the full-length
FIG. 1. ESI mass spectra of hen egg lysozyme with and without
copper(II) as negative control. To 10 mM lysozyme (A) at pH 7.4, 50
mM (B) and 100 mM (C) copper sulfate were added, respectively.
TABLE I
Molecular masses for the copper binding of the prion protein and its
fragments calculated from ESI mass spectra
Peptide/Protein Mass (amu) Dm (amu)
humPrP60–91 3125.0 6 0.1
3187.1 6 0.5 62.1
3248.3 6 0.1 61.2
3309.6 6 0.3 61.3
3371.4 6 0.2 61.8
Average 5 61.6
humPrP60–109 5061.9 6 0.5
5123.4 6 2.0 61.5
5184.5 6 0.7 61.1
5246.3 6 0.5 61.8
5306.8 6 0.6 60.5
5367.4 6 1.1 60.6
Average 5 61.1
humPrP23–98 7813.0 6 0.8
7873.9 6 1.7 60.9
7936.4 6 1.2 62.5
7998.1 6 1.2 61.7
8059.2 6 1.2 61.1
8121.2 6 1.2 61.9
8184.0 6 0.6 62.8
Average 5 61.8
humPrP23–112 9355.4 6 0.3
9416.6 6 0.9 61.2
9478.4 6 0.6 61.8
9540.3 6 0.7 61.9
9600.5 6 0.8 60.1
9660.8 6 1.5 60.3
Average 5 61.1
murPrP121–231 13335.5 6 0.7
13397.3 6 1.5 Average 5 61.8
murPrP23–231 23110.6 6 3.1
23171.9 6 2.1 61.3
23233.7 6 3.8 61.8
23294.5 6 4.3 60.8
23355.7 6 2.7 61.2
23418.2 6 2.8 62.5
Average 5 61.5






















































prion protein murPrP23–231. The experimental conditions for
metal interaction studies at pH 7.4 with respect to suitable
buffers and additives were intensively investigated. Finally, we
introduced N-ethylmorpholine at pH 7.4 as a new buffer system
for metal interaction studies with ESI MS, because it did not
interfere with copper binding to peptides and protein compared
with ammonium salt-containing buffers. Furthermore, addi-
tion of solvents like acetonitrile or methanol significantly af-
fected the copper population in the ESI mass spectra (data not
shown) and were therefore omitted. To avoid unspecific binding
the copper concentration as well as the peptide concentration
were kept as low as possible.
For a negative control experiment we used hen egg lysozyme,
since it is similar to the prion protein with respect to its size
and isoelectric point. Besides the potential unspecific copper
binding sites at the N-terminal amino group as well as C-
terminal and side chain carboxyl groups, it has one histidine at
amino acid position 15 just after the first helix, which is ex-
posed to the solvent. As clearly shown in the spectra of ly-
sozyme with (Fig. 1, B and C) and without copper (Fig. 1A),
even at a 10-fold excess of free copper(II) no significant binding
occurred. For the first and second copper adduct mass differ-
ences of 61.7 and 61.3 average mass units were obtained,
respectively. The low unspecific copper binding to lysozyme as
a negative control demonstrated that NEMO is an excellent
new buffer system for copper interaction experiments with
proteins at a physiological pH of 7.
ESI mass spectrometry of the N-terminal fragments (Fig. 2)
FIG. 2. ESI mass spectra of PrPC and its fragments with and without copper(II) at pH 7.4. A, C, E, G, I, and K show the mass spectra
of the apopeptides/proteins of humPrP60–91, humPrP60–109, humPrP23–98, humPrP23–112, murPrP121–231, and murPrP23–231. B, D, F, H, J,
and L represent the mass spectra of the corresponding holopeptides of 20 mM humPrP60–91, 10 mM humPrP60–109, 10 mM humPrP23–98, 10 mM
humPrP23–112, 13 mM murPrP121–231, and 10 mM murPrP23–231 with 100 mM copper(II) and 70 mM copper(II) for humPrP23–98, respectively. If present,
open circles indicate m/z peaks for the apopeptides. The triangles in C and G mark the m/z peaks of by-products (see “Results”). The diamonds
in D mark the m/z peaks for two copper ions bound to the by-product and not for the apopeptide of humPrP60–109.






















































resulted in the expected average masses for the apopeptides of
humPrP60–91, humPrP60–109, and humPrP23–98 (Table I). In the
spectrum of apo humPrP60–109, a by-product (Fig. 2C, marked
with triangles) with a corresponding mass of 4934.3 amu is
observed. The mass difference of 127.6 suggests a missing
lysine or glutamine residue in the by-product. The mass calcu-
lated from the spectrum of humPrP23–112 (Fig. 2G) was 1 amu
higher than the theoretically expected 9354.2 amu. This is
probably due to the hydrolysis of Asn108 to Asp108 (25). The
same holds for the by-product (marked with triangles) for
which a mass of 8958.6 amu was obtained. The mass difference
indicated that the three C-terminal amino acids KHM after
Met109 have been cleaved off from humPrP23–112.
Adding a 5–10-fold excess of copper(II) to the apopeptides
resulted in mass spectra (Fig. 2, B, D, F, and H) with several
copper adduct peaks. On addition of 100 mM copper sulfate to 20
mM humPrP60–91, new m/z peaks appeared (Fig. 2B) corre-
sponding to up to four bound copper(II) per peptide molecule.
The two small peaks between the two following m/z copper
peaks are always due to unspecific sodium and potassium
adducts commonly observed in mass spectrometry of peptides
and proteins at neutral pH. Adding 100 mM copper(II) to 10 mM
humPrP60–109 resulted in the appearance of additional m/z
peaks due to the complex formation of up to five bound copper
per humPrP60–109 (Fig. 2D). Note that the peaks apparently
corresponding to zero (marked by diamonds) and one bound
copper for humPrP60–109 are also the main peaks for the by-
product with two and three bound copper, because their masses
differ only by 4 amu and thus appeared as poorly resolved
double peaks. Addition of 70 mM copper(II) to 10 mM
humPrP23–98 (Fig. 2F) led to the appearance of m/z peaks for
up to six bound copper ions. It should be noted that adding a
10-fold excess (data not shown) above all significantly raised
the intensity of the m/z peaks for six bound copper ions, sug-
gesting a less specific copper binding site. In contrast, only
adduct peaks for up to five bound copper were observed on
addition of 100 mM copper sulfate to 10 mM of the 14 amino acids
longer humPrP23–112 (Fig. 2H). The significant shift of m/z
peaks to lower charge values z and thus higher m/z values on
addition of copper suggests conformational changes associated
with copper binding, resulting in a more folded or structured
conformation compared with the apopeptides.
The structured C-terminal domain of the prion protein
murPrP121–231 was analyzed by ESI mass spectrometry (Fig.
2I) and yielded a mass of 13335.5, which corresponds to the
expected average molecular weight of 13334.8. On addition of
up to 100 mM copper to 13 mM protein, only one bound copper
was observed (Fig. 2J). This could be seen easier from the
deconvoluted spectra (Fig. 3A). This site appears to be of lower
affinity, because at 20 mM copper(II), which is the 1.5-fold
excess in copper, only a peak of little intensity is observed. At
40 mM copper (a 3-fold excess of copper) the apoprotein peak
almost disappeared, and the molecular weight peak for one
bound copper became prominent. This remained almost un-
changed, increasing the copper concentration up to 100 mM and
indicating that there is probably one copper-binding site with
lower affinity in murPrP121–231. In contrast to the N-terminal
fragments, there is no shift of the m/z charge envelope to lower
values. Thus, presumably no conformational change occurs on
binding of the copper ion.
From the mass spectrum of the apoprion protein murPrP23–231
(Fig. 2K) an average mass of 23110.6 with a S.D. of 3.1 is
obtained, which is about 6 amu higher than the expected mo-
lecular mass of 23104.4. The reason for this difference was
unclear. On addition of up to 100 mM copper, several not very
well resolved copper adduct peaks (Fig. 2L) appeared. Due to
the broad half-peak width and the high charges, the copper
adduct peaks could be observed better from the deconvoluted
FIG. 3. Deconvoluted ESI mass
spectra of murPrP121–231 (A) and
murPrP23–231 (B) at different copper
concentrations (see the labeling of
curves). The concentrations of
murPrP121–231 and murPrP23–231 were 13
and 10 mM, respectively. Peaks labeled
with Cu, K, and Na represent the corre-
sponding adducts for copper, sodium,
and potassium.






















































spectra (Fig. 3B). The deconvoluted spectra showed molecular
weight peaks for up to five bound copper on addition of 20–100
mM copper. In contrast to the preceding spectra (20, 40, 60, and
80 mM) there are only minor changes in the spectra going from
80 to 100 mM copper, suggesting a saturation of murPrP23–231
with copper.
The average molecular masses for all used peptides and
proteins are summarized in Table I. From this table the aver-
age mass differences between the copper sites almost corre-
sponds to 61.5 amu, which is typically observed in copper(II)
binding ESI mass spectrometry experiments. Because the av-
erage mass of copper is 63.5 amu, the difference of 2 amu is
explained as displacement of two hydrogens on binding of each
copper ion (M 1 nzCu 2 2znzH1).
Comparing the results of humPrP60–109, humPrP23–98, and
humPrP23–112 only to humPrP23–98, an additional sixth copper
ion appears to be bound. For humPrP23–112, which is almost
identical to humPrP23–98 but C-terminally extended, only five
bound copper were observed. Also humPrP60–109, which shares
an almost identical C-terminal extension to the octarepeat
region, binds only five copper ions. Therefore the binding of a
sixth copper ion to humPrP23–98 appears to be an unspecific
copper-binding site. Thus up to five copper ions appear to be
bound specifically to humPrP60–109, humPrP23–98, and
humPrP23–112, whereas four copper ions are bound to the oct-
arepeat region, suggesting an additional copper-binding site
within the N-terminal segment. Because the additional copper-
binding site occurs already in humPrP60–109, which is com-
pared with humPrP60–91 C-terminally extended, this addi-
tional binding site has to be located C-terminally of the
octarepeat region.
Fluorescence Titration of PrPC and Its N-terminal Fragments
with Copper—Fluorescence measurement and quantification of
the copper binding to PrPC and its fragments were difficult
with respect to some items. First, to prevent unspecific binding
of copper to PrPC and its fragments, 100 mM NaCl was in-
cluded. Second, to prevent unspecific aggregation and adsorp-
tion to surfaces 1 mM DTAC was added at a concentration
clearly below critical micelle concentration (26). Third, for the
quantification of affinities the peptide or PrPC concentrations
were chosen to be significantly lower than the dissociation
constants, to assume that the free copper concentration is
approximately equal to the added copper concentration.
Fourth, in contrast to, e.g. calcium, the fluorescence of peptides
and proteins is not only quenched by conformational changes
induced by copper(II) binding but also by diffusion-controlled
collision of copper(II) with tryptophan and tyrosine side chains
(27–29). Thus fluorescence titration curves have to be recorded
at copper concentrations far beyond the saturation point to get
quantitative data from the fluorescence titration curves.
The fluorescence titration curves with copper(II) for the N-
terminal fragments humPrP60–91, humPrP60–109, humPrP23–98,
and humPrP23–112; the structured C-terminal fragment mur-
PrP121–231; as well as for the full-length recombinant
murPrP23–231 are shown in Fig. 4, A–F. All curves, except that
for murPrP121–231, show more or less clearly visible sigmoidal
changes in fluorescence intensity upon addition of copper, sug-
gesting a basic cooperative binding mechanism. It appears that
the peptides/protein cannot be saturated with copper at high
concentrations. This is due to collisional quenching, which can
be shown by plots according to the Stern-Volmer equation (28),
Fo/F 5 1 1 KSV z @Q# (Eq. 1)
where F is the fluorescence at the individual concentration of
the quencher [Q] (which is copper in this case), Fo is the initial
FIG. 4. Fluorescence titration curves of the prion protein and its fragments with copper(II). A shows the fluorescence data of 170 nM
humPrP60–91 (octarepeat), B of 145 nM humPrP60–106, C of 125 nM humPrP23–98, D of 120 nM humPrP23–112, E of 85 nM murPrP23–231, and F of 125
nM murPrP121–231. Lines represent the results of nonlinear regression analyses according to Equation 3. The insets represent Stern-Volmer plots
of fluorescence data according to Equation 1. The result of linear regression analysis at high copper concentrations is indicated by a straight line.






















































fluorescence without quencher, and KSV is the quenching con-
stant also called the Stern-Volmer constant. Above the satura-
tion point of copper binding to the peptides or protein, the
changes of Fo/F should be linear in Stern-Volmer plots if this is
only due to collisional quenching. Indeed, with the exception of
murPrP121–231 (Fig. 4F, inset) the linearity in the Stern-Volmer
plots of PrPC and its N-terminal fragments (Fig. 4, A—E,
insets) showed that the fluorescence changes above ;30–50 mM
are the result of collisional quenching. The nonlinearity of the
Stern-Volmer plot for murPrP121–231 might be explained by the
different excitation wavelength of 285 nm instead of 295 nm
used for reasons of sensitivity. The fluorescence of murPrP121–231,
which has 11 tyrosines and only 1 tryptophan, probably reflects
not only the Trp fluorescence but also the fluorescence of
tyrosines, which are expected to have different dynamic copper-
quenching properties.
From these Stern-Volmer plots, the Stern-Volmer constants
as well as the fraction of conformational fluorescence change
caused by binding of copper fconf are calculated by linear re-
gression analysis at high copper concentrations. For this pur-
pose Equation 1 has to be modified, because it is only valid
where exclusively collisional quenching occurs. In the presence
of conformational fluorescence changes true values for KSV can
be calculated, introducing a correction factor according to
Equation 2.
Fo/F 5 ~1 1 KSV z @Q#!/~1 2 fconf! (Eq. 2)
where fconf is the fraction of conformational fluorescence
changes. Thus to obtain the true value for KSV the slopes from
the Stern-Volmer plots have to be divided by the value of the
ordinate 1/(1 2 fconf). The Stern-Volmer plots yield values for
fconf and KSV (Table II). The Stern-Volmer constant is used
later to fit fluorescence data by nonlinear regression to obtain
copper binding data. The values for KSV represent a measure
for the accessibility of tryptophan residues. For humPrP60–109,
humPrP23–98, and humPrP23–112, KSV decreases from almost
4000 M21 to about 2500 M21, suggesting that the tryptophans
become more buried in the holopeptides with longer fragment
size. The reason for the at least 5–10-fold higher value for
murPrP23–231 is not known but has to be an effect of the
C-terminal domain. Although the Stern-Volmer plot of
murPrP121–231 (Fig. 4F, inset) could not be fitted very well with
Equation 2, a similar Stern-Volmer constant of 22,000 M21
could be estimated considering only data from 30 to 80 mM
copper.
From the fluorescence titration curves (Fig. 4, A–E) it is
apparent that there is a significant increase in affinity for
copper(II) going from humPrP60–91 (Fig. 4A) to humPrP60–109
(Fig. 4B). Again a small increase in affinity can be observed
going further to humPrP23–98 (Fig. 4C), whereas the affinities
of humPrP23–98 and humPrP23–112 (Fig. 4D), as well as for the
full-length recombinant murPrP23–231 (Fig. 4E) seem to be
identical.
To get quantitative copper binding data the titration curves
were fitted by nonlinear regression analysis. ESI mass spec-
trometry has confirmed that four copper ions bind to the oct-
arepeat region (humPrP60–91). The mass spectrometry data
suggest that one additional copper binding site exists for
humPrP60–109, humPrP23–98, humPrP23–112, and murPrP23–
231. This site was assumed to be independent, because partic-
ularly the titration curves for humPrP23–98, humPrP23–112, and
murPrP23–231 could only be fitted with a mathematical term for
an independent binding site. Assuming almost equal fluores-
cence changes per cooperative binding site, data of titration
curves were fitted according to Equation 3,
Frel 5 $1 2 find z @Cu21#/~Kind 1 @Cu21#! 2 fcoop z @Cu21#n/~~Kcoop!n
1 @Cu21#n!%/~1 1 KSVz[Cu
21]) (Eq. 3)
where Frel is the relative fluorescence; find and Kind are the
fraction of fluorescence change and the dissociation constant
for the independent binding site, respectively; fcoop, Kcoop, and n
are the fractional fluorescence change, the dissociation con-
stant, and the Hill coefficient for the four cooperative binding
sites, respectively; KSV is the Stern-Volmer constant; and
[Cu21] is the free copper concentration. Because the peptide/
protein concentration was chosen to be significantly lower than
the dissociation constants, the added or total copper concentra-
tion was assumed to be equal to the free copper concentration.
For the fitting procedure the Stern-Volmer constants obtained
from Stern-Volmer plots were inserted for KSV in Equation 3.
Equation 3 was applied to all fluorescence titration curves
except for humPrP60–91, because only cooperative binding sites
were assumed, and thus the term for the independent site was
omitted. The same held for murPrP121–231, but n was set to 1,
because mass spectrometry suggested binding of only one cop-
per ion, and thus no cooperative binding can occur.
The quantitative data (Table II) show that C- and N-terminal
extensions in the sequence of the octarepeat region
humPrP60–91 have a significant influence on both dissociation
constant Kcoop and Hill coefficient n. The dissociation constants
for the cooperative binding of four copper ions to the octarepeat
region decrease significantly from 5.5 to 2.5 mM for
humPrP60 –91 and finally only slightly to 2.2 mM for
humPrP23–98, humPrP23–112, and murPrP23–231. Also Hill coef-
ficients significantly increase from 2.4 to values ranging from
3.6 to 4.2 for humPrP60–109, humPrP23–98, humPrP23–112, and
murPrP23–231, suggesting almost perfect cooperativity for the
four cooperative copper-binding sites in the full-length prion
protein. Similar changes in the dissociation constant are ob-
served for the independent binding site. Here the values for
Kind significantly decreases from 8.8 mM to values between 1.4
and 2.4 mM for humPrP23–98, humPrP23–112, and murPrP23–231.
TABLE II











humPrP60–91 3230 0.53 (0.53) —
d —d 5.5 0.53 2.4
humPrP60–109 3980 0.71 (0.73) 8.8 0.25 2.5 0.48 3.7
humPrP23–98 3490 0.76 (0.78) 1.4 0.19 2.2 0.58 3.6
humPrP23–112 2560 0.72 (0.73) 2.4 0.25 2.2 0.48 3.7
murPrP23–231 22500 0.75 (0.76) 1.8 0.28 2.2 0.48 4.2
a Data obtained by fitting with modified Stern-Volmer Equation 2.
b Data obtained by fitting to Equation 2 data in parentheses are the sum of find and fcoop.
c Data obtained by fitting to Equation 3.
d Only cooperative sites were assumed and thus fitted without a mathematical term for an independent site (Equation 3).






















































For the one putative copper-binding site in murPrP121–231, a
dissociation constant of about 8 mM was estimated considering
that no precise mathematical fitting was obtained (see Fig. 4F).
DISCUSSION
Here we present for the first time affinity and stoichiometry
data on the copper binding to humPrP60–109, murPrP121–231,
and the full-length prion protein murPrP23–231 under physio-
logical conditions as well as for humPrP23–112 representing a
natural cleavage product of the prion protein (30, 31). Our
results clearly demonstrate that the full-length prion protein
binds copper within the physiological concentration range with
binding of five copper ions per molecule. Furthermore, we
proved that the positive cooperativity of copper binding is not
restricted to N-terminal fragments but is a property of the
full-length protein. The systematical comparison of the data for
full-length PrP with C- and N-terminal fragments indicates
that the N-terminal segment represents the cooperative cop-
per-binding domain of the prion protein.
Mass spectrometry has evolved as a method in the assess-
ment and elucidation of copper and heavy metal binding stoi-
chiometry of proteins and peptides (32, 33). In contrast to
Whittal et al. (34) we used ESI MS only for the copper binding
stoichiometry studies for several reasons. First, our fluores-
cence affinity data indicated the copper binding sites of the
prion protein and its fragments to be almost saturated with
copper under the chosen concentrations in ESI MS. Therefore,
it is expected to obtain mass spectra where predominantly the
four or five copper adduct peaks are observed. This is not the
case as readily visible from the spectra (see Fig. 2). It might be
explained by the high flexibility of the N-terminal copper bind-
ing domain and thus its higher sensitivity to mechanical stress
during the spraying procedure than more classical copper bind-
ing domains in which the copper binding sites are surrounded
by several stabilizing secondary structure elements (35). Thus
the ESI mass spectra appear not to reflect quantitatively the
situation in solution but rather qualitatively for the prion pro-
tein and its peptides. Second, further investigations showed
that ESI spectra are quite sensitive to changes of buffer and
additives. The effect of ammonium salts on the ESI mass spec-
tra of humPrP60–91 compared with NEMO as buffer is shown in
Fig. 5. In contrast to the ammonium buffer system the third
and fourth copper-binding sites are significantly populated us-
ing the N-ethylmorpholine instead. Additionally, the use of
Tris with a functional primary amine prevented copper binding
to humPrP58–91 in CD spectroscopy experiments (17). Summa-
rized, ESI mass spectrometry of copper binding to prion protein
and peptides appears to be quite sensitive to the chosen buffer
and additive conditions. Therefore we have introduced N-eth-
ylmorpholine as new buffer system in ESI mass spectrometry
for metal interaction studies at a physiological pH of 7.
Our finding that the octarepeat region (humPrP60–91) binds
four copper ions confirmed earlier mass spectrometry (13, 34)
and circular dichroism spectroscopy data (17). The mass spec-
tra of humPrP60–109, humPrP23–98, and humPrP23–112 revealed
one additional copper-binding site. This is in good agreement
with the binding of 5.6 copper(II) ions to humPrP23–98 from our
earlier equilibrium dialysis experiments (18). From these ex-
periments, as well as from the mass spectrum of humPrP23–98
(Fig. 2C), a sixth binding site, which was also observed earlier
(34), might be assumed. But because only five copper ions were
observed for humPrP60–109 and humPrP23–112, this site has to
be unspecific. The involvement of the N-terminal amino group
of humPrP23–98 for the unspecific site was proved by N-termi-
nal acetylation (34).
Mass spectrometry data showed binding of up to five copper
ions to the full-length protein, confirming one additional cop-
per-binding site compared with the four of the octarepeat re-
gion. The data for the structured C-terminal domain
murPrP121–231 containing three histidine residues revealed one
possible copper-binding site with an estimated dissociation con-
stant of 8 mM. This affinity is probably too low to be of physio-
logical significance. For copper dissociation constants in the
micromolar range, at least two side chains are essential from
which one has to be a histidine or cysteine residue (36). Looking
for this site in the three-dimensional NMR structure of the
C-terminal fragment, we found a site made up of His140,
Asp147, and Met138. These residues are on the surface and close
enough to each other (distance: ;5 Å).
In contrast to the putative C-terminal copper(II)-binding site
for the fifth binding site in humPrP23–98, humPrP23–112, and
full-length prion protein, we obtained a dissociation constant of
about 2 mM. Since the additional fifth copper is already bound
by humPrP60–109, it has to occur C-terminal of the octarepeat
region. This binding site might be located at His96, because it is
known that besides the cysteine residue, the histidyl side chain
is the major copper-binding site in peptides and proteins (36).
In structured proteins at least two ligands, e.g. two histidine
side chains, are necessary for copper binding in the micromolar
concentration range (37). In flexible peptides without second-
ary structure only one histidine is essential for the copper
binding. In such peptides the peptide backbone can adopt con-
formations in which peptide bond nitrogen is involved as a
ligand in copper binding after deprotonation (38). Histidine
hinders deprotonation of peptide bonds in the C-terminal posi-
tion but promotes the deprotonation of N-terminally located
peptide bonds as for N-acetyl-Gly-Gly-Gly-His (36). In this
tetrapeptide the abstraction of the three adjacent peptide-bond
hydrogens, together with the imidazole nitrogen, results in a
4N coordinated copper complex. The sequence at His96 . . .
-Gly-Gly-Gly-Thr-His- . . . is strikingly similar to N-acetyl-Gly-
Gly-Gly-His, but also His112 might be involved in copper bind-
ing. Further investigations are required to clarify the role of
His96, His112, or His140 in the copper binding of prion protein.
The sigmoidal form of fluorescence titration curves for the
prion protein and its N-terminal fragments clearly indicated an
underlying positive cooperative binding mechanism. This
agreed well with CD spectroscopy data for humPrP58–91, which
is almost identical to our octarepeat fragment humPrP60–91
(17). In contrast, Whittal et al. (34) have obtained individual
dissociation constants for humPrP58–91 clearly indicating a
FIG. 5. Relative population of the individual copper binding
sites for the ESI mass spectra of humPrP60–91 for different buff-
ers. The spectra were recorded from either NEMO or an ammonium-
containing buffer at pH 7.4 at a final concentration of 1 mM. 100 mM
copper sulfate was added to 18 mM peptide.






















































negative cooperativity. This is probably explained by the limi-
tations of ESI mass spectrometry in quantitative analysis and
the buffer conditions as discussed above. Our results demon-
strate that the positive cooperative copper binding is not re-
stricted to the octarepeat fragment but is a general feature of
the full-length prion protein.
The fluorescence data for humPrP60–91 yielded a cooperative
dissociation constant of 5.5 mM, which is almost identical to the
value of 6 mM for humPrP58–91 obtained by CD spectroscopy
(17). Compared with equilibrium dialysis experiments for
humPrP23–98 with a dissociation constant of 5.9 mM (18), we
have calculated significantly lower dissociation constants of 2.2
and 1.4 mM for the cooperative and the assumed independent
site, respectively. This might be explained by the different
experimental conditions. Our affinity data for humPrP60–91
and humPrP23–98 are difficult to compare with those obtained
by quantitative ESI MS (34) for the already mentioned reasons
and because we have obtained one cooperative constant instead
of four individual constants from which only two were calcula-
ble in the case of humPrP23–98 (34).
The similarity of the fluorescence titration curves of
humPrP23–98 and humPrP23–112 with the full-length prion pro-
tein murPrP23–231 as well as the obtained data (Table II) indi-
cated that the N-terminal segment is a copper-binding domain.
The putative low affinity copper-binding site in the C-terminal
domain (murPrP121–231) apparently had no influence on the
copper-binding mode and affinity of the N-terminal segment.
Although the total N-terminal segment up to amino acid 126 is
highly flexible, C- and N-terminal extensions of the octarepeat
region (humPrP60–91) have a significant influence on the affin-
ity and cooperativity of the independent and cooperative bind-
ing sites, respectively. They clearly increase if the octarepeat
region is C-terminally extended to humPrP60–109 (Table II).
The affinity of the assumed independent site becomes signifi-
cantly higher on N-terminal sequence extension from
humPrP60–109 to humPrP23–98 or humPrP23–112. Thus the flu-
orescence data of the four cooperative sites as well as for the
assumed independent site indicated that there are additional
interactions stabilizing the holocopper-binding domain.
Fluorescence titration curve data show that the full-length
murPrP23–231 is almost saturated at about 5 mM copper(II). This
is within the physiological concentration range of the total
copper concentration in blood plasma of 18.6 mM (39). But this
concentration does not represent the physiologically available
copper pool, because about 10.2 mM copper (65%) is bound to
ceruloplasmin in a nonexchangeable way. In contrast about 2.8
mM is bound to serum albumin, 1.9 mM to transcuprein, and 3.6
mM is bound to low molecular weight components like amino
acids in an exchangeable way. Considering only the copper pool
of 3.6 mM bound by low molecular weight components and the
copper affinities of the prion protein, there is strong argument
for a direct role of the prion protein in copper metabolism.
Additionally, copper concentrations ranging from 0.5 to 2.5 mM
are found in the cerebrospinal fluid, whereas 15 mM is present
in the synaptic cleft (40). In contrast to blood plasma the
conditions at the synaptic cleft and in the cerebrospinal fluid
are probably different in that no ceruloplasmin, serum albu-
min, or transcuprein is present.
The cooperative copper-binding mode of the prion protein
within the physiological concentration range suggests two pos-
sible functions. First, similar to the cooperative oxygen binding
of hemoglobin, it might play a role in copper transport. Second,
the prion protein might be a copper sensor similar to the
intracellular calcium-binding protein calmodulin, which also
binds calcium in a cooperative way.
In mammals, relatively little is currently known about the
precise components involved in copper transport and the mech-
anism by which copper is transported across the plasma mem-
brane into cells (41). Cellular copper uptake by the prion pro-
tein might be similar to transferrin, which is mediated by
endocytosis. Both transferrin and prion protein release their
bound iron and copper at an acidic pH of 5.0 (15). A possible
transport function for PrPC is supported by the stimulation of
endocytosis with copper (42), the pH-dependent copper binding
(17), and the lower copper content of brain in PrPC-deficient
mice (18). This was recently further supported by our results
showing that PrPC is apparently located in presynaptic mem-
branes and that the loss of PrPC in Prnp0/0 mice strongly
affected the copper content of synaptosomes (14). This suggests
that PrPC is involved in the synaptic copper homeostasis.
The in vivo binding mode of copper to the prion protein is not
yet known. Even if PrPC does not bind copper under normal
conditions, it might serve as an extracellular copper sensor. It
is known that cancer and infections increase plasma copper
concentrations in blood (39). Thus it might be that PrPC binds
copper and regulates cells on increasing copper concentration.
Copper binding to PrP appears to play a role in the prion
disease as well (43). Copper apparently stabilized prions, be-
cause it enhances the regeneration of partially denatured PrPSc
(5). Our finding of a low affinity copper-binding site in the
C-terminal domain of PrPC might be interesting for the confor-
mational change to PrPSc.
Further investigations are necessary to explore the molecu-
lar nature of the unique, cooperative, copper binding motif in
the octarepeat region as well as to elucidate the role of copper
binding for the prion protein in vivo.
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2. Post, K., Pitschke, M., Schäfer, O., Wille, H., Appel, T. R., Kirsch, D.,
Mehlhorn, I., Serban, H., Prusiner, S. B., and Riesner, D. (1998) Biol. Chem.
379, 1307–1317
3. McKinley, M. P., Bolton, D. C., and Prusiner, S. B. (1983) Cell 35, 57–62
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11. Büeler, H., Aguzzi, A., Sailer, A., Greiner, R.-A., Autenried, P., Aguet, M., and
Weissmann, C. (1993) Cell 73, 1339–1347
12. Lledo, P. M., Tremblay, P., DeArmond, S. J., Prusiner, S. B., and Nicoll, R. A.
(1996) Proc. Natl. Acad. Sci. U. S. A. 93, 2403–3407
13. Hornshaw, M. P., McDermott, J. R., and Candy, J. M. (1995) Biochem. Biophys.
Res. Commun. 207, 621–629
14. Herms, J., Tings, T., Gall, S., Madlung, A., Giese, A., Siebert, H., Schürrmann,
P., Windl, O. Brose, N., and Kretzschmar, H. (1999) J. Neurosci. 19,
8866–8875
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